U.S. stocks extend slide, one day after Fed’s rate hike
Investors remain focused on what the market thinks is an overly hawkish Fed stance
All Posts in "Markets"
Dollar skids lower ahead of expected Fed policy decision
‘Today’s main risk event for financial markets will be the Federal Reserve’: says FXTM analyst
Kroger rolls out driverless cars to deliver groceries
Kroger rolls out driverless cars to deliver groceries
An earnings double whammy may add fuel to the fire on Wall Street
FedEx and Micron sound alarms in late-season reports that suggest a global economic slowdown
U.S. stocks rise modestly ahead of Fed meeting; market expects ‘dovish hike’
All eyes are on the Federal Reserve
European markets drop, as gloom spreads to online retailers
H&M tumbles 9% as retailer take a hit
Oil prices hit fresh lows as supply worries plague market
WTI crude hovers at $48 a barrel
All the biggest stocks that are now in a bear market, in one chart
There are some BIG names in bear territory right now.
Oracle stock rises as earnings, cloud revenue narrowly top Wall Street estimates
Company buys back $10 billion in stock over quarter
Netflix reportedly set to produce 90 movies a year, with budgets up to $200 million
Streaming giant sets sights on Oscars
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Tweaking one setting on mechanical ventilators may help protect patients from lung injury
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
While FDA mulls Zevra’s rare disease med, Rafael merges with Cyclo to push their rival candidate
Despite mixed market, a venture capital revival could be coming in Europe: PitchBook
Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain
Ex-GSK CEO takes up board post at aging and obesity biotech BioAge
After $213M round, gene editing biotech Tome shrinks operations as investor sentiment worsens
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration